NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.90
-0.20 (-1.00%)
At close: Mar 4, 2026

TPEX:4732 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9351,2301,3431,7372,5341,207
Market Cap Growth
-13.59%-8.42%-22.70%-31.42%109.96%5.06%
Enterprise Value
3967458301,2252,072769
Last Close Price
19.9025.0023.7330.1743.5520.65
PE Ratio
-1371.24132.7257.8782.2418.47
PS Ratio
5.195.488.397.6010.143.93
PB Ratio
1.301.572.122.714.062.02
P/TBV Ratio
1.431.732.252.904.392.21
P/FCF Ratio
--21.70125.4275.1422.10
P/OCF Ratio
--21.59125.4275.1421.72
EV/Sales Ratio
2.203.325.185.368.292.51
EV/EBITDA Ratio
--84.3832.9954.5111.74
EV/EBIT Ratio
--241.6746.5176.8013.28
EV/FCF Ratio
-17.53-13.4188.4561.4514.09
Debt / Equity Ratio
0.010.000.010.000.010.01
Debt / EBITDA Ratio
--0.560.070.170.04
Debt / FCF Ratio
--0.130.200.200.05
Net Debt / Equity Ratio
-0.80-0.78-0.74-0.77-0.79-0.78
Net Debt / EBITDA Ratio
15.25109.75-47.53-13.23-12.92-7.16
Net Debt / FCF Ratio
25.40209.86-7.55-35.46-14.57-8.60
Asset Turnover
0.240.290.230.330.370.49
Inventory Turnover
1.161.251.021.712.222.93
Quick Ratio
10.3013.359.8113.038.2410.67
Current Ratio
11.8915.2811.5514.529.1211.54
Return on Equity (ROE)
-7.05%-0.51%1.59%4.74%5.04%11.55%
Return on Assets (ROA)
-3.70%-0.98%0.31%2.36%2.47%5.72%
Return on Invested Capital (ROIC)
-30.38%-7.10%2.17%18.60%20.59%43.62%
Return on Capital Employed (ROCE)
-6.10%-1.50%0.50%4.10%4.20%9.50%
Earnings Yield
-3.96%0.07%0.75%1.73%1.22%5.41%
FCF Yield
-2.41%-0.24%4.61%0.80%1.33%4.52%
Dividend Yield
--0.84%1.66%0.69%0.46%
Payout Ratio
-1098.88%243.53%49.25%15.09%-
Buyback Yield / Dilution
1.14%0.15%-0.85%-0.30%0.05%-30.58%
Total Shareholder Return
1.14%0.15%-0.01%1.36%0.74%-30.12%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.